Eye blood flow imaging study with investigational device
Part of Eyes & vision clinical trials.
This study uses a new imaging device called XyCAM CRE to take detailed pictures of blood vessels in the back of your eye. Researchers will compare these pictures with standard eye exam images to see if the new device works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 21 years old
- You must have vision in both eyes
- You cannot be pregnant
- Your eyes must be relatively clear (no significant scarring or cloudiness)
- You must be able to follow instructions and hold your eyes steady during imaging
- You must not have severe nearsightedness or farsightedness (more than 15 diopters)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special camera (OCT) to capture detailed images of the eye. It aims to improve eye disease detection. You may join if you have retinal disease, glaucoma, corneal disease, or healthy eyes.
This study uses special imaging to look at blood flow in the eye to help assess or better understand glaucoma. You may be eligible if you’re an adult with eye exams that fit the study’s specific eye-health and imaging requirements.
This study uses a special camera to take very detailed pictures of blood flow in the retina (the light-sensitive part at the back of your eye). It aims to better understand normal eye blood flow in healthy young adults.
This trial studies whether a new, very high-resolution and high-speed eye scan can be used for people with eye problems or for healthy volunteers. It may help doctors better “see” eye structures more clearly to guide care.
This research study tests a new camera technology that takes detailed pictures of the back of your eye (retina) to better understand eye diseases. Researchers want to compare images from people with eye conditions like diabetes-related eye disease, glaucoma, or age-related macular degeneration with healthy volunteers to see how the new imaging works.
This early safety study tests how well and how safely an investigational dye (MB-102) works during a special eye imaging test of retinal and choroidal blood vessels. It compares it to the commonly used fluorescein dye and may help doctors refine future eye imaging approaches.
Hear when a new Microvascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.